Search

everythinglearnresearchcommunity

for

Search:↓

A rare case links early-onset alopecia universalis and nephrotic syndrome, suggesting genetic immune issues.

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

Folliculin helps regulate energy and nutrient sensing, impacting Birt–Hogg–Dubé syndrome.

The regenerative solution, tSVF, is a safe and effective treatment for various conditions like aged skin, scars, wounds, and more, but more research is needed to find the best way to use it.

IL-18 levels are higher in hidradenitis suppurativa patients and may indicate disease severity.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

A woman’s skin bumps healed almost completely with tretinoin cream after a leg infection.

Hepatitis C treatment may cause frontal fibrosing alopecia.

CD34⁺ cells help heal damaged limbs by promoting blood vessel growth.

A 16-year-old boy's facial condition improved with doxycycline, suggesting an immune response to hair follicle damage.

Fetuin A may increase collagen production and promote scarring.

Truncated LTBP-1 disrupts TGF-beta signaling, affecting hair growth.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Injectable platelet-rich fibrin may stop hair loss from Discoid lupus erythematosus.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Two sisters had rare, widespread cysts and complete hair loss, suggesting a genetic link.

These ovarian conditions cause high testosterone levels.

Skin ulcers from interferon may not depend on the amount given.

A possible link exists between minimal change nephrotic syndrome and complete hair loss.

Keratinocytes grew and migrated into hair follicle areas but disappeared after 15-20 days.

Different types of fibroblasts play various roles in both healthy and diseased tissues, and understanding them better could improve treatments for fibrotic diseases.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.